660PSafety and efficacy of a DKK1 inhibitor (DKN-01) in combination with pembrolizumab (P) in patients (Pts) with advanced gastroesophageal (GE) malignancies. (23rd October 2018) - Klempner, S J; Bendell, J; Meucci Villaflor, V; Tenner, L; Stein, S; Sirard, C A; Newman, W; Kagey, M; Schlienger, K; Strickler, J